SAU · 4019.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:18 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Specialized Medical Company’s quoted price sits in the lower half of its reported 52-week range, 39.65% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Specialized Medical Company’s next earnings report is currently expected on Nov 10, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Specialized Medical Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Riyadh, Saudi Arabia, and established in 1994, Specialized Medical Company operates an extensive network of hospitals, clinics, and medical centers throughout the Kingdom. Its diverse activities are categorized into two primary segments: Medical Services, and Pharmacies & Other Offerings. The company delivers a full spectrum of medical care, encompassing both diagnostic and therapeutic treatments across numerous specialties. These include urgent care, cardiology, internal and family medicine, and pediatrics. Essential ancillary services are also provided, such as laboratory diagnostics (including histopathology), advanced imaging (radiology and nuclear medicine), anesthesiology, pharmaceutical supply, and physiotherapy rehabilitation. Furthermore, Specialized Medical Company boasts comprehensive surgical capabilities, with specialized units for operating rooms, post-operative recovery, maternity (delivery), ophthalmology, general surgery, obstetrics and gynecology, urology, orthopedics, and ear, nose, and throat (ENT) procedures. Critical care is a key offering, featuring specialized intensive care units for neonates (NICU), cardiac patients (CCU), and general critical conditions (ICU). Beyond conventional medicine, the company extends its portfolio to include dermatology, anti-aging, aesthetic services, home healthcare, virtual consultations, and dentistry. In addition to its healthcare provisions, the company's "Pharmacies & Other" segment encompasses a range of services such as the provision of prepared and unprepared food, maintenance for hospital and other facilities, and the management and operation of restaurants, alongside other non-medical, healthy food, and food-related enterprises.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SAR 221.50-SAR 1.60 (-0.72%)
Dr. Sulaiman Al Habib Medical Services Group Company’s quoted price sits in the lower half of its reported 52-week range, 18.57% below the high.
SAR 55.20-SAR 0.40 (-0.72%)
Mouwasat Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 64.95-SAR 0.65 (-0.99%)
Dallah Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 49.09% below the high.
SAR 30.32-SAR 0.06 (-0.2%)
Dr. Soliman Abdul Kader Fakeeh Hospital Co.’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 103.00+SAR 0.10 (+0.1%)
Almoosa Health Company’s quoted price sits in the lower half of its reported 52-week range, 48.96% below the high.
SAR 102.10+SAR 3.50 (+3.55%)
National Medical Care Company’s quoted price sits in the lower half of its reported 52-week range, 42.87% below the high.
SAR 21.43-SAR 0.07 (-0.33%)
Al Hammadi Holding Company’s quoted price sits in the lower half of its reported 52-week range, 38.81% below the high.
SAR 23.65-SAR 0.43 (-1.79%)
Middle East Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 54.08% below the high.
